Stay updated on Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedThe Plain Language Summary section has been removed from the study record. This reduces the lay-friendly overview of the trial’s purpose and design for readers.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page's revision metadata was updated to v3.6.5, replacing the previous v3.6.4. This reflects a system update rather than a change to the study content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a new backend revision, v3.6.4, with recent date entries, while the previous revision v3.6.3 is removed. This reflects an administrative update to the page rather than changes to trial details or eligibility.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a deployment update to the page template. This is a maintenance update and does not modify the study content or data.SummaryDifference0.0%

- Check52 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a small update to the page's software or content. This reflects a maintenance release rather than a change to visible study information.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows 'No longer looking for participants' and adds new help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also updates the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and notes a revision change from v3.5.5 to v3.6.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Chemo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemo in Bladder Cancer Clinical Trial page.